Genes like NRG1, OLFM1, and WDR62, associated with both tumor progression and neuropsychiatric symptoms such as fatigue and depression, highlight the neuroimmune signature as a potential marker of disease severity and a target to mitigate extrahepatic manifestations in chronic hepatitis. This evidence concerns the gene OLFM1 and chronic hepatitis.